UC San Diego Extension’s Healthcare Department has announced a continuing education agreement with Universidad de las Américas in Puebla, Mexico to partner on delivering a Certificate program in Clinical Trials.
Leonel Villa-Caballero: "Our program has been fully adapted for the cultural and professional context of Latin America."
Clinical Trials in Latin America — a certificate which is offered online and in Spanish — has been available for the past five years. The new agreement with Puebla makes access to and knowledge of the program for students and clinical professionals in Mexico even more available.
“Our program has been fully adapted for the cultural and professional context of Latin America,” said UC San Diego Extension instructor Leonel Villa-Caballero, MD, PhD, the program director. “In this way, we can all learn from each other.”
A physician and clinical researcher with a background in internal medicine, endocrinology-metabolism and public health, Villa-Caballero is currently a researcher in Family and Preventive Medicine at the UC San Diego School of Medicine.
According to Villa-Caballero, the city of Puebla has become a magnet for pharmaceutical and biotech companies in Latin America, North America, and Europe, especially those looking to implement new and innovative products through clinical trials.
Clinical trials are held to evaluate the effectiveness and safety of proposed medications or medical devices by testing and monitoring their effects on large groups of people. Trials involve proposed, non-market pharmaceutical products that are intended to cure or ease the dilatory effects of such diseases as cancer, diabetes, Alzheimer’s, Parkinson’s, osteoporosis as well as cardiovascular and rheumatoid illnesses, and others.
Located southeast of Mexico City with a metro population of 2.6 million, Puebla is the largest city in the Mexican state of Puebla.